SD

Subir Dutta

Active Director Director DIN 10635132
DIN 10635132 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Subir Dutta

Data last updated:

Subir Dutta is a Director at Kansas Laboratories Pvt Ltd (since 2024). The company operates in Pharma. Kansas Laboratories Pvt Ltd reported revenue of ₹15.04 Cr (FY 2025).

DIN 10635132
Primary Designation Director
Industry Pharma
First Appointment 15 May 2024
Oldest Company Age 40 yrs
Largest company Kansas Laboratories Pvt Ltd · ₹15.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kansas Laboratories Pvt Ltd U27109WB1986PTC041462
Director15 May 20241986₹15.04 Cr (FY 2025)Active

Board colleagues of Subir Dutta

Directorship timeline

Open interactive timeline →
Kansas Laboratories Pvt Ltd
Premium access

Shareholding and investment profile for Subir Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subir Dutta

Subir Dutta currently holds 1 directorship: Kansas Laboratories Pvt Ltd (Director, since 15 May 2024, revenue ₹15.04 Cr (FY 2025)).

Subir Dutta was first appointed on 15 May 2024 as Director at Kansas Laboratories Pvt Ltd.

The current boards of Subir Dutta's companies include Anil Kumar Shah (Kansas Laboratories Pvt Ltd), Dipak Kumar Kantilal Shah (Kansas Laboratories Pvt Ltd), Neerav Shah (Kansas Laboratories Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available